双氢麦角毒治疗脑血管疾病120例  

Dihydroergotoxine in treating 120 patients with cerebrovascular diseases

作　　者：王月樵[1] 李晓玲[1] 刘红兵[1] 

机构地区：[1]青岛市人民医院神经科

出　　处：《中国新药与临床杂志》1998年第2期87-89,共3页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：目的：观察双氢麦角毒治疗脑血管疾病的疗效。方法：脑血管疾病病人１２０例（男性８１例，女性３９例，年龄５８±ｓ８ａ），其中口服治疗组６０例，给予双氢麦角毒２．５ｍｇ，ｐｏ，ｂｉｄ；注射组６０例病人给双氢麦角毒０．３ｍｇ，ｉｍ，ｑｄ，均３０ｄ为一个疗程，作口服和注射给药临床症状改善比较。另用相似３０例为对照组，给予曲克芦丁１００ｍｇ，ｐｏ，ｂｉｄ，也是３０ｄ为一个疗程。结果：口服双氢麦角毒疗效显著优于曲克芦丁（Ｐ＜０．０１）；注射双氢麦角毒临床症状改善优于口服。结论：双氢麦角毒有改善脑血管疾病病人因脑血管循环障碍引起的脑部症状。AIM: To observe the threapeutic effects of dihydroergotoxine in patients with cerebrovascular diseases. METHODS: In the 120 patients with cerebrovascular diseases (M 81, F 39; age 58±s 8 a), sixty patients were treated with dihydroregotoxine 2.5 mg, po, bid. The another 60 patients were treated with dihydroergotoxine 0.3 mg, im,qd,all for 30 d. The control group(30 patients) took troxerutin 100 mg, po, bid. RESULTS: Dihydroergotoxine showed better effects than that of troxerutin (P<0.01). The injection group was better than the oral group. CONCLUSION: dihydroergotoxine improve cerebral symptoms due to cerebrovascular disturbances.

关 键 词：双氢麦角毒 曲克芦丁 脑血管疾病 药物疗法 

分 类 号：R743.05[医药卫生—神经病学与精神病学]